On this page · 9 sections→
Where the EU money came from. €28.0M across 3 programmes.
Amounts are Asociacion Centro de Investigacion Cooperativa en Biociencias Cic Biogune's own share of each project, not the project's full budget.
- Horizon Europe€12.8M30 projects46% of its EU funding
- Horizon 2020€12.5M22 projects45% of its EU funding
- FP7 (2007 to 2013)€2.6M6 projects9% of its EU funding
EU projects over time. 2008 to today, by start year.
As coordinatorAs partnerShow as table
| Start year | Projects | As coordinator | Its EU share |
|---|---|---|---|
| 2008 | 1 | 0 | €288k |
| 2011 | 1 | 1 | €256k |
| 2012 | 1 | 1 | €100k |
| 2013 | 2 | 1 | €1.9M |
| 2014 | 1 | 1 | €100k |
| 2015 | 4 | 2 | €812k |
| 2016 | 2 | 1 | €555k |
| 2017 | 3 | 2 | €2.1M |
| 2018 | 2 | 1 | €2.7M |
| 2019 | 5 | 3 | €4.9M |
| 2020 | 2 | 1 | €187k |
| 2021 | 4 | 1 | €1.2M |
| 2022 | 6 | 1 | €1.5M |
| 2023 | 4 | 3 | €2.1M |
| 2024 | 9 | 5 | €2.4M |
| 2025 | 4 | 2 | €2.8M |
| 2026 | 3 | 1 | €2.9M |
| 2027 | 4 | 3 | €1.2M |
Open calls in its fields. Matched to its research and past grants.
5 live now- Horizon EuropeOpens soonAdvancing bio-printing of living cells for regenerative medicineDeadline16 Sept 2027cells technologiesbiomaterials
- Horizon EuropeOpenDevelopment of novel small molecule antiviral therapeutics for pathogens with epidemic potentialDeadline17 Feb 2027antivirals
- Horizon EuropeOpenDevelopment of cell-free protein synthesis platforms for discovery and/or production of biologicalsDeadline17 Feb 2027cells technologies
- Horizon EuropeOpens soonSustainable and Competitive Cell Production Techniques for Lithium-ion And Sodium-ion Batteries (BATT4EU Partnership)Deadline31 Mar 2027cells technologies
- Horizon EuropeOpenDevelopment of innovative antimicrobials against pathogens resistant to antimicrobialsDeadline17 Feb 2027antibiotic resistanceantibiotics
Calls like these, matched to your own organisation instead of Asociacion Centro de Investigacion Cooperativa en Biociencias Cic Biogune. Free with an EUACC account.
Projects
58 EU-funded projects, newest first. Asociacion Centro de Investigacion Cooperativa en Biociencias Cic Biogune led 30 of them as coordinator. Each links to the official record.
- GLYCODECD44Coordinator
Unravelling Glycosylation Codes in Cancer at the Molecular Level: An Interdisciplinary Approach for the Dissection of the Recognition Features of CD44 by Galectins and Selectins
Horizon Europe · 2027–2029 · Project on CORDIS ↗
€194ktheir share - GlycoScopeCoordinator
Glycoproteins with homogeneous glycosylation to define unexplored lectin binding properties
Horizon Europe · 2027–2029 · Project on CORDIS ↗
€194ktheir share - ProofReadingCoordinator
European doctoral network for proofreading the proteome
Horizon Europe · 2027–2030 · Project on CORDIS ↗
€564ktheir share - GlyCaBiotaPartner
Doctoral Training Network on Glycan–Cancer–Microbiota Interactions for Therapeutic and Diagnostic Innovation in Colorectal cancer
Horizon Europe · 2027–2030 · Project on CORDIS ↗
€282ktheir share - VaccinNateCoordinator
From adjuvants-based vaccines for inflammatory diseases to refined vaccine adjuvants
Horizon Europe · 2026–2028 · Project on CORDIS ↗
€194ktheir share - RGNcestryPartner
Tracing and harnessing the ancestry of RNA-guided nucleases
Horizon Europe · 2026–2032 · Project on CORDIS ↗
€2.4Mtheir share - EVADEREPartner
Enhanced VAccines DEsign against antimicrobial REsistance
Horizon Europe · 2026–2029 · Project on CORDIS ↗
€282ktheir share - UnMissCoordinator
Uncovering the hidden origin behind the missing heritability
Horizon Europe · 2025–2030 · Project on CORDIS ↗
€2.0Mtheir share - IMMUFELLOWAssociated partner
Interdisciplinary and Intersectoral Research Fellowship Program for Future Leaders in Immunology
Horizon Europe · 2025–2030 · Project on CORDIS ↗
- BiParatopicCoordinator
Bispecific bi-paratopic antibodies for the treatment of cancer
Horizon Europe · 2025–2026 · Project on CORDIS ↗
€150ktheir share - InFlaMePartner
Counter-acting the pandemic potential of flaviviruses: addressing virus-host interactions and defense strategies to design new therapeutics against WNV and DENV
Horizon Europe · 2025–2028 · Project on CORDIS ↗
€625ktheir share - CARAMELPartner
CArdiovascular Risk Assessment in MEnopausaL women via multimodal data analysis enabling personalized prevention strategies
Horizon Europe · 2024–2029 · Project on CORDIS ↗
€816ktheir share - ADJUPROBECoordinator
LEAD ADJUVANT PROBE AS A DUAL TECHNOLOGICAL TOOL TO ADVANCE NEXT-GENERATION VACCINE DEVELOPMENT
Horizon Europe · 2024–2026 · Project on CORDIS ↗
€150ktheir share - MagFetProgCoordinator
Magnesium and fetal metabolic programming: an approach to preventing a life-cycle of metabolic diseases
Horizon Europe · 2024–2027 · Project on CORDIS ↗
€194ktheir share - EPIMemoryCoordinator
Epithelial Memory to Candida albicans during commensalism and infection
Horizon Europe · 2024–2026 · Project on CORDIS ↗
€165ktheir share - SPIRALCoordinator
Structural exploration of GD3 ganglioside-COVID spike Protein Interaction and siglec-7 Role in inhibition of virAL infection
Horizon Europe · 2024–2026 · Project on CORDIS ↗
€169ktheir share - ADJU-PLATFORMCoordinator
MINIMAL SAPONIN-BASED ADJUVANT VACCINE PLATFORM
Horizon Europe · 2024–2025 · Project on CORDIS ↗
€150ktheir share - ENSCCPartner
European Network on the Supramolecular Chemistry of Carbohydrates
Horizon Europe · 2024–2028 · Project on CORDIS ↗
€252ktheir share - GLYCO-NPartner
GLYCOprotein N-glycosylation from non-life to eukaryotes: a Doctoral Network to expand the knowledge on a ubiquitous posttranslational modification of proteins
Horizon Europe · 2024–2028 · Project on CORDIS ↗
€252ktheir share - PLIADESPartner
AI-Enabled Data Lifecycles Optimization and Data Spaces Integration for Increased Efficiency and Interoperability
Horizon Europe · 2024–2027 · Project on CORDIS ↗
€203ktheir share - Glyco13CellCoordinator
Isotopically labelling of cell surface glycans to illuminate infectious processes at atomic resolution
Horizon Europe · 2023–2028 · Project on CORDIS ↗
€1.5Mtheir share - CARESCoordinator
Human ECM-based platform for anti-cancer drug testing - CARES (CAncer dRug tESting)
Horizon Europe · 2023–2027 · Project on CORDIS ↗
€51ktheir share - ADJUVACCINECoordinator
Development of a marketable adjuvant candidate for vaccine applications
Horizon Europe · 2023–2024 · Project on CORDIS ↗
€150ktheir share - CoDietPartner
COMBATTING DIET RELATED NON-COMMUNICABLE DISEASE THROUGH ENHANCED SURVEILLANCE
Horizon Europe · 2023–2026 · Project on CORDIS ↗
€406ktheir share - GLYCOTwinningPartner
GLYCOTwinning: Building Networks to Excel in Glycosciences
Horizon Europe · 2022–2025 · Project on CORDIS ↗
€234ktheir share - halt-RONINPartner
Discovering chronic inflammation biomarkers that define key stages in the Healthy-to-NASH (non-alcoholic steatohepatitis) transition to inform early prevention and treatment strategies
Horizon Europe · 2022–2026 · Project on CORDIS ↗
€535ktheir share - EVCAPartner
Centre for Excellence in Diagnostic and Advanced Therapeutics based on Extracellular Vesicles
Horizon Europe · 2022–2026 · Project on CORDIS ↗
€208ktheir share - R-NMRPartner
Remote NMR (R-NMR): Moving NMR infrastructures to remote access capabilities
Horizon Europe · 2022–2025 · Project on CORDIS ↗
€50ktheir share - SPIDVACPartner
Improved control of priority animal diseases: Novel vaccines and companion diagnostic tests for African horse sickness, peste des petits ruminants and foot-and-mouth disease
Horizon Europe · 2022–2026 · Project on CORDIS ↗
€294ktheir share - FIH-IOCoordinator
Development of a first-in-class inhibitor of FIH for cancer immunotherapy
Horizon Europe · 2022–2023 · Project on CORDIS ↗
€150ktheir share - CD28Coordinator
Probing CD28 as checkpoint for T cell co-stimulation in cancer and infection
Horizon 2020 · 2021–2024 · Project on CORDIS ↗
€246ktheir share - PIPgenPartner
PI3K/PTEN-related monogenic disease to understand cancer
Horizon 2020 · 2021–2025 · Project on CORDIS ↗
€251ktheir share - BioUPGRADEPartner
Biocatalytic upgrading of natural biopolymers for reassembly as multipurpose materials
Horizon 2020 · 2021–2025 · Project on CORDIS ↗
€501ktheir share - GLYTUNESPartner
A multidisciplinary training network for the bioinspired development of glycomimetics tuning the Siglec-Sialoglycan axis
Horizon 2020 · 2021–2025 · Project on CORDIS ↗
€251ktheir share - MyeRIBOPartner
Deconstructing the Translational Control of Myelination by Specialized Ribosomes
Horizon 2020 · 2020–2026 · Project on CORDIS ↗
€14ktheir share - QS21-MechCoordinator
Target identification and elucidation of the molecular mechanism of action of saponin vaccine adjuvants QS-21 (QS21Mech)
Horizon 2020 · 2020–2022 · Project on CORDIS ↗
€173ktheir share - CancerADAPTCoordinator
Targeting the adaptive capacity of prostate cancer through the manipulation of transcriptional and metabolic traits
Horizon 2020 · 2019–2025 · Project on CORDIS ↗
€2.0Mtheir share - proEVLifeCyclePartner
The life cycle of extracellular vesicles in prostate cancer: from biogenesis and homing, to functional relevance
Horizon 2020 · 2019–2023 · Project on CORDIS ↗
€251ktheir share - BactiVaxPartner
anti-Bacterial Innovative Vaccine Training Network.
Horizon 2020 · 2019–2024 · Project on CORDIS ↗
€502ktheir share - GlycoMabsCoordinator
Chemoenzymatic glyco-engineering of therapeutic monoclonal antibodies
Horizon 2020 · 2019–2021 · Project on CORDIS ↗
€161ktheir share
Show 18 more projects
- NextGen IOCoordinator
Exploiting the hypoxia response in T cells for Next-Generation Immuno-Oncology
Horizon 2020 · 2019–2024 · Project on CORDIS ↗
€2.0Mtheir share - RECGLYCANMRCoordinator
Breaking the limits in glycan recognition by NMR
Horizon 2020 · 2018–2024 · Project on CORDIS ↗
€2.5Mtheir share - UbiCODEPartner
European Research Training to Decipher The Ub Code : identification of potential biomarkers and drug targets
Horizon 2020 · 2018–2022 · Project on CORDIS ↗
€248ktheir share - LITMUSPartner
Liver Investigation: Testing Marker Utility in Steatohepatitis
Horizon 2020 · 2017–2024 · Project on CORDIS ↗
€403ktheir share - MetaboMARKERCoordinator
A metabolism-based prognostic biomarker for prostate cancer
Horizon 2020 · 2017–2018 · Project on CORDIS ↗
€150ktheir share - ADJUV-ANT VACCINESCoordinator
Elucidating the Molecular Mechanisms of Synthetic Saponin Adjuvants and Development of Novel Self-Adjuvanting Vaccines
Horizon 2020 · 2017–2022 · Project on CORDIS ↗
€1.5Mtheir share - €297ktheir share
- FCSSSLPCoordinator
First Chemoselective Synthesis and Structural Studies of Lasso Peptides
Horizon 2020 · 2016–2019 · Project on CORDIS ↗
€257ktheir share - GLYCOVAXPartner
A training network for the rational design of the next generation of well-defined glycoconjugate vaccines
Horizon 2020 · 2015–2019 · Project on CORDIS ↗
€248ktheir share - SchmaVirusVacDiagCoordinator
Novel vaccine and diagnostic strategies against Schmallenberg virus
Horizon 2020 · 2015–2017 · Project on CORDIS ↗
€158ktheir share - ACMCoordinator
Cholesterol metabolism as a driver of prostate cancer aggressiveness
Horizon 2020 · 2015–2017 · Project on CORDIS ↗
€158ktheir share - TOLLerantPartner
Toll-Like Receptor 4 activation and function in diseases: an integrated chemical-biology approach.
Horizon 2020 · 2015–2018 · Project on CORDIS ↗
€248ktheir share - THE NASCENT CODECoordinator
Unravelling the Nascent Code: Signals sensed and transmitted by the nascent chain to acquire its functional state or reprogram gene expression
FP7 (2007 to 2013) · 2014–2018 · Project on CORDIS ↗
€100ktheir share - ANTIDOTEPartner
Anti-tick Vaccines to Prevent Tick-borne Diseases in Europe
FP7 (2007 to 2013) · 2013–2018 · Project on CORDIS ↗
€373ktheir share - CANCERMETABCoordinator
Metabolic requirements for prostate cancer cell fitness
FP7 (2007 to 2013) · 2013–2019 · Project on CORDIS ↗
€1.5Mtheir share - PTENLKB1Coordinator
Implication of energy sensing pathways in prostate cancer biology
FP7 (2007 to 2013) · 2012–2016 · Project on CORDIS ↗
€100ktheir share - UPSTREAMCoordinator
European Research Training in the Ubiquitin Proteasome System
FP7 (2007 to 2013) · 2011–2015 · Project on CORDIS ↗
€256ktheir share - NANOTHERPartner
Integration of Novel Nanoparticle based Technology for Therapeutics and Diagnosis of different types of Cancer
FP7 (2007 to 2013) · 2008–2012 · Project on CORDIS ↗
€288ktheir share
Where its partners are. 38 countries across its EU projects.
- France22
- United Kingdom21
- Germany19
- Italy19
- Netherlands18
- Denmark10
Also outside Europe: United States, Israel, South Africa, Canada, Colombia, Japan, South Korea, Singapore.
Works most with
Organisations that shared the most EU projects with this one. A good starting list for consortium partners.
- Centre National de la Recherche Scientifique CNRSFrance · 10 shared projects
- Imperial College of Science Technology and MedicineUnited Kingdom · 6 shared projects
- Universidade Nova de LisboaPortugal · 5 shared projects
- Universidad del Pais Vasco/ Euskal Herriko UnibertsitateaSpain · 5 shared projects
- Kobenhavns UniversitetDenmark · 4 shared projects
- Institut National de la Sante et de la Recherche MedicaleFrance · 4 shared projects
- Consiglio Nazionale Delle RicercheItaly · 4 shared projects
- Ludwig-Maximilians-Universitaet MuenchenGermany · 4 shared projects
- Academisch Ziekenhuis LeidenNetherlands · 4 shared projects
- Universitat de BarcelonaSpain · 4 shared projects
- Johann Wolfgang Goethe-Universitaet Frankfurt am MainGermany · 4 shared projects
- Universita Degli Studi di Napoli Federico IiItaly · 4 shared projects
- Universita Degli Studi di FirenzeItaly · 4 shared projects
- Atlas Molecular Pharma SLSpain · 4 shared projects
- Max-Planck-Gesellschaft zur Forderung der Wissenschaften eVGermany · 3 shared projects
- Agencia Estatal Consejo Superior de Investigaciones CientificasSpain · 3 shared projects
Build the consortium. Inside your AI.
Connect EUACC to Claude, ChatGPT or Grok. Your AI searches nearly 117,000 EU-funded organisations and every open call, then shortlists partners like Asociacion Centro de Investigacion Cooperativa en Biociencias Cic Biogune by field, track record, role and country.
Connect with your free EUACC account. See how it works
Asociacion Centro de Investigacion Cooperativa en Biociencias Cic Biogune already works most with these organisations. A good place to start:
| Organisation | Country | Shared projects |
|---|---|---|
| Centre National de la Recherche Scientifique CNRS | France | 10 |
| Imperial College of Science Technology and Medicine | United Kingdom | 6 |
| Universidade Nova de Lisboa | Portugal | 5 |
| Universidad del Pais Vasco/ Euskal Herriko Unibertsitatea | Spain | 5 |
Want me to check each one against the call conditions and find a coordinator with a recent track record?
Illustration. Partners from Asociacion Centro de Investigacion Cooperativa en Biociencias Cic Biogune's EU record.
Fields it works in. From the research fields on its EU projects.
- SectorAI/MLEU funding, calls and companies
- SectorSaaSEU funding, calls and companies
- SectorSpaceTechEU funding, calls and companies
- SectorBioTechEU funding, calls and companies
- SectorAgriTechEU funding, calls and companies
- DNA
- agriculture
- alkaline earth metals
- allergology
- animal husbandry
- antibiotic resistance
- antibiotics
- antivirals
- artificial intelligence
- asthma
- bacteriology
- biochemistry
- biological interactions
- biomaterials
Is this your organisation?
Claim it with an EUACC listing (€39 once, reviewed by our editors): add what you build, your team and what you are looking for. We pre-fill it from your EU records. Listed companies reach investors through our newsletter and get matched to new EU calls first.
Claim this profile →Source: CORDIS (Horizon Europe, Horizon 2020, FP7) and the EU Funding & Tenders Portal (other EU programmes), matched by the EU registration number (PIC). Past participation does not mean the organisation is open to new partnerships. Official website ↗



